Fredag 27 December | 16:46:04 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-02-12 08:00 Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2024-05-22 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-02-14 - Bokslutskommuniké 2023
2023-12-29 - Extra Bolagsstämma 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2023-05-17 - Årsstämma
2023-05-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-09-27 - Extra Bolagsstämma 2022
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-15 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-09-14 - Extra Bolagsstämma 2021
2021-08-17 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2021-05-20 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-16 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Neola Medical är verksamt inom medicinteknik. Bolaget är inriktade mot neonatalvården där de utvecklar medicinteknisk utrustning. Exempel på produkter som bolaget tillhandahåller till sjukvården inkluderar teknisk övervakning och uppföljning av lungkapaciteten hos tidigt födda spädbarn. Utöver huvudprodukten erbjuds kringprodukter och engångsartiklar. Störst verksamhet återfinns inom den nordiska marknaden. Bolaget gick tidigare under namnet GPX Medical.
2024-11-20 07:00:00

Neola Medical AB will deliver a live, on-site presentation at Stora Aktiedagarna in Stockholm on November 26, 2024 at 11:20 CET (11.20). CEO Hanna Sjöström will present the company’s latest advancements, highlight the potential of Neola®, the company’s advanced medical technology device for continuous lung monitoring, and outline the strategic plans for achieving FDA approval and preparing for market launch in the U.S. Join the event live in Stockholm to watch the presentation and have the opportunity to pose questions to CEO Hanna Sjöström during the Q&A session immediately following, by registering for in-person attendance at the link here: https://invitepeople.com/events/ade744dfee

"I am excited to engage with investors and attendees in Stockholm, where I will discuss Neola Medical’s significant business advancements and outline our strategic plans toward launching in the U.S. market. We have made pivotal progress toward our FDA application, including the initiation of the essential clinical validation phase, as we prepare for our first pivotal study on preterm born infants in the U.S.”, says CEO Hanna Sjöström.

If unable to attend in Stockholm, the presentation will be streamed online at the following link: https://invitepeople.com/public/events/ade744dfee/pages/ad355f8861

The presentation will also be accessible for viewing afterward on our company website at www.neolamedical.com

About Stora Aktiedagarna
Stora Aktiedagarna in Stockholm is a three-day, action-packed event featuring around 60 company presentations from both large and small businesses. The purpose of Stora Aktiedagarna is to provide investors with objective information about the companies participating in the event. Objective information includes insights delivered directly from company leadership during their presentations, as well as questions posed by moderators to these companies. The goal is to offer the best possible information for making well-informed investment decisions. Additionally, the event aims to inspire active participation in investments and to deepen knowledge of the stock market and equity investing.